{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:54:55Z","timestamp":1764251695680,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.nefro.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T07:26:49Z","timestamp":1622273209000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum sclerostin in acute kidney injury patients"],"prefix":"10.1016","volume":"42","author":[{"given":"Ahmed","family":"Fayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina O.","family":"Abdulazim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Elhadidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussien H.","family":"Samir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim M.","family":"Abd ElAzim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled El Sayed","family":"El Hawary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama A.","family":"Sharaf El Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2021.01.010_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nefro.2021.01.010_bib0090","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2021.01.010_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.nefro.2021.01.010_bib0100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2021.01.010_bib0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/0886022X.2020.1741386","article-title":"Association of sclerostin with cardiovascular events and mortality in dialysis patients","volume":"42","author":"Zou","year":"2020","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefro.2021.01.010_bib0110","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ki.2015.194","article-title":"Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification","volume":"88","author":"Qureshi","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2021.01.010_bib0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/nep.12813","article-title":"Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D","volume":"22","author":"Wang","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nefro.2021.01.010_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000443845","article-title":"High serum sclerostin levels are associated with a better outcome in haemodialysis patients","volume":"132","author":"Jean","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2021.01.010_bib0125","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","article-title":"Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients","volume":"99","author":"Kanbay","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2021.01.010_bib0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s10067-019-04878-7","article-title":"Evaluating the role of serum sclerostin as an indicator of activity and damage in Egyptian patients with rheumatoid arthritis: university hospital experience","volume":"39","author":"Fayed","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.nefro.2021.01.010_bib0135","article-title":"Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients [published online ahead of print, 2020 Aug 20]","author":"Zeng","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefro.2021.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00404-020-05656-6","article-title":"Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome","volume":"302","author":"Wyskida","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.nefro.2021.01.010_bib0145","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.nefro.2021.01.010_bib0150","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2215\/CJN.05571008","article-title":"Nonrecovery of kidney function and death after acute on chronic renal failure","volume":"4","author":"Hsu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2021.01.010_bib0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/0886022X.2018.1455594","article-title":"Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients","volume":"40","author":"Fayed","year":"2018","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefro.2021.01.010_bib0160","article-title":"High serum fibroblast growth factor 23 level is associated with metabolic syndrome in kidney transplantation patients [published online ahead of print, 2020 May 16]","author":"Chen","year":"2020","journal-title":"Transplant Proc"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021169952100093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021169952100093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:56:06Z","timestamp":1759323366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021169952100093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S021169952100093X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2021.01.010","relation":{},"ISSN":["0211-6995"],"issn-type":[{"type":"print","value":"0211-6995"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum sclerostin in acute kidney injury patients","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}